Hints and tips:
Related Special Reports
...The president has also repeatedly emphasised the importance of the “real economy” in contrast to finance and tech, as part of a campaign for “high-quality development”....
...Roughly a quarter of the funding comes via an equity investment, with the remainder composed of research grants and commitments for joint business development that will not dilute shareholders, said people...
...David Moore, vice-president for corporate development, added that the company would focus on acquisitions in diabetes and obesity, ideally in the early stage of development....
...The Development Bank of Japan is investing in 4Bio, which funds companies in the UK and Europe, alongside the Japanese pharma group Kyowa Kirin, and US healthcare provider, Children’s Minnesota. 4Bio aims...
...Dementia Mission and chief executive of Alzheimer’s Research UK....
...Since the third quarter of 2023 when it had 82 new drugs in development, the company has jettisoned 16 drugs and added 12 others, including the weight-loss drug it gained through its $3.1bn acquisition of...
...Developing new antibiotics is often unattractive for pharmaceutical companies, as research and development costs are high but their use is designed to be limited to reduce the risk of the product driving...
...Specification: Cognition and Development Click the link below to read the and then answer the questions: US seeks up to 50-year sentence for FTX founder Sam Bankman-Fried According to his lawyers quoted...
...The company’s vertically integrated structure, economies of scale and ballooning research and development plans mark a stark challenge to companies in the west, analysts say....
...JSW said it aimed to bring down the cost of MG’s EVs by supplying its own steel, in addition to batteries, and carrying out more research and development in India....
...It will be part of a $40bn investment made by the company in capabilities ranging from the manufacturing of microprocessors to advanced chip packaging and research and development work....
...The research charity noted there had been improvements in diagnosing and treating the disease in the years since the latest trial, conducted by the universities of Bristol, Oxford and Cambridge, began....
...The results from the research, which involved 156 people, were a “major breakthrough”, said Olivier Rascol, a Toulouse University Hospital professor and a co-author of the research with Prof Wassilios Meissner...
...Todd Rosenbluth, head of research at VettaFi, a New York-based consultancy, said: “If this becomes prevalent, we could see a slowdown in product development, because this would an additional cost to launching...
...A dearth of career scientists and public funding risks undermining efforts to use technological breakthroughs to tackle the biggest health threats, the head of a leading international research organisation...
...Martin Holst Lange, head of development at Novo Nordisk, said that Cardior’s drug had the “potential to become a first-in-class therapy designed to halt or partially reverse the course of disease for people...
...Thomson is a professor of experimental particle physics at the University of Cambridge and executive chair of the Science and Technology Facilities Council, a UK research organisation....
...Jodie Keane Senior Research Fellow ODI (Formerly Overseas Development Institute), London SE1, UK...
...Carmakers from America to Europe to Asia are already facing rising costs from new technology development and tougher emissions rules, while also struggling to develop cheap electric vehicles that they can...
...“The development of models that can better replicate human diseases and accurately predict human responses promises to improve the outcomes of drug-development programmes,” said Silvia Velasco, an associate...
...As healthcare systems around the world put pressure on drug prices, pharma companies are also looking for ways to cut costs in research and development....
...Susan Galbraith, executive vice-president of oncology research and development at AstraZeneca, said there was an “opportunity to improve” on existing drugs in the area and that the Fusion acquisition would...
...The UK government said in a statement: “Research and the life sciences are crucial in the fight against cancer, which is why we invest £1bn per year through the National Institute for Health and Care Research...
...The reliance on animal testing brings further risks to the human subjects of clinical trials, and to the drug development process as a whole, Quantiphi argued....
...The National Institute for Health and Care Excellence announced on Tuesday that it would not approve the medication Enhertu, developed by pharmaceutical companies Daiichi Sankyo and AstraZeneca, to treat...
International Edition